In fiscal year 2025, Chabiotech (085660) reported revenue of 1.27 trillion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 1.27 trillion KRW | -48.8 billion KRW | -146.7 billion KRW | [source] |
| 2024 | 1.05 trillion KRW | -59.7 billion KRW | -14.6 billion KRW | [source] |
| 2023 | 954.0 billion KRW | -9.6 billion KRW | -5.6 billion KRW | [source] |
| 2022 | 844.6 billion KRW | -47.1 billion KRW | -69.7 billion KRW | [source] |
| 2021 | 727.5 billion KRW | 7.7 billion KRW | -21.8 billion KRW | [source] |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 929.3 billion KRW | 454.2 billion KRW | 475.1 billion KRW | [source] |
| 2024 | 704.7 billion KRW | 401.3 billion KRW | 303.4 billion KRW | [source] |
| 2023 | 426.4 billion KRW | 175.0 billion KRW | 251.4 billion KRW | [source] |
| 2022 | 395.4 billion KRW | 145.9 billion KRW | 249.5 billion KRW | [source] |
| 2021 | 398.2 billion KRW | 87.5 billion KRW | 310.6 billion KRW | [source] |
